Advertisement
Screener

ATARA BIOTHERAPEUTICS, INC. (ATRA) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

ATARA BIOTHERAPEUTICS, INC. Capital Expenditures

ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Capital Expenditures of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-16

  • ATARA BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • ATARA BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
  • ATARA BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • ATARA BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
  • ATARA BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • ATARA BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $246.00K, a 79.89% decline from fiscal 2023.
  • ATARA BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $1.22M, a 70.83% decline from fiscal 2022.
  • ATARA BIOTHERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $4.19M, a 60.37% decline from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 4 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$0.00
derived: sum of 2 quarters · filed 2026-03-16
$0.00
derived: sum of 3 quarters · filed 2026-03-16
$0.00
10-K · filed 2026-03-16
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$0.00
derived: sum of 2 quarters · filed 2025-11-12
$0.00
10-Q · filed 2025-11-12
$90.00K
derived: sum of 4 quarters · filed 2026-03-16
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$0.00
10-Q · filed 2025-08-11
$90.00K
derived: sum of 3 quarters · filed 2026-03-16
$90.00K
derived: sum of 4 quarters · filed 2026-03-16
2025-03-31$0.00
10-Q · filed 2025-05-15
$90.00K
derived: sum of 2 quarters · filed 2026-03-16
$90.00K
derived: sum of 3 quarters · filed 2026-03-16
$119.00K
derived: sum of 4 quarters · filed 2026-03-16
2024-12-31$90.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$90.00K
derived: sum of 2 quarters · filed 2026-03-16
$119.00K
derived: sum of 3 quarters · filed 2026-03-16
$246.00K
10-K · filed 2026-03-16
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$29.00K
derived: sum of 2 quarters · filed 2025-11-12
$156.00K
10-Q · filed 2025-11-12
$200.00K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$29.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$156.00K
10-Q · filed 2025-08-11
$200.00K
derived: sum of 3 quarters · filed 2025-08-11
$481.00K
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31$127.00K
10-Q · filed 2025-05-15
$171.00K
derived: sum of 2 quarters · filed 2025-05-15
$452.00K
derived: sum of 3 quarters · filed 2025-05-15
$951.00K
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$44.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
$325.00K
derived: sum of 2 quarters · filed 2025-03-07
$824.00K
derived: sum of 3 quarters · filed 2025-03-07
$1.22M
10-K · filed 2025-03-07
2023-09-30$281.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$780.00K
derived: sum of 2 quarters · filed 2024-11-12
$1.18M
10-Q · filed 2024-11-12
$1.22M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$499.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
$898.00K
10-Q · filed 2024-08-12
$935.00K
derived: sum of 3 quarters · filed 2024-08-12
$1.07M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31$399.00K
10-Q · filed 2024-05-09
$436.00K
derived: sum of 2 quarters · filed 2024-05-09
$568.00K
derived: sum of 3 quarters · filed 2024-05-09
$1.99M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$37.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$169.00K
derived: sum of 2 quarters · filed 2024-03-28
$1.59M
derived: sum of 3 quarters · filed 2024-03-28
$4.19M
10-K · filed 2024-03-28
2022-09-30$132.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$1.55M
derived: sum of 2 quarters · filed 2023-11-01
$4.16M
10-Q · filed 2023-11-01
$6.62M
derived: sum of 4 quarters · filed 2023-11-01
2022-06-30$1.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$4.02M
10-Q · filed 2023-08-08
$6.49M
derived: sum of 3 quarters · filed 2023-08-08
$10.35M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$2.60M
10-Q · filed 2023-05-08
$5.07M
derived: sum of 2 quarters · filed 2023-05-08
$8.93M
derived: sum of 3 quarters · filed 2023-05-08
$10.99M
derived: sum of 4 quarters · filed 2023-05-08
2021-12-31$2.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08
$6.32M
derived: sum of 2 quarters · filed 2023-02-08
$8.38M
derived: sum of 3 quarters · filed 2023-02-08
$10.58M
10-K · filed 2023-02-08
2021-09-30$3.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$5.92M
derived: sum of 2 quarters · filed 2022-11-08
$8.11M
10-Q · filed 2022-11-08
$8.71M
derived: sum of 4 quarters · filed 2023-02-08
2021-06-30$2.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$4.26M
10-Q · filed 2022-08-08
$4.86M
derived: sum of 3 quarters · filed 2023-02-08
$5.36M
derived: sum of 4 quarters · filed 2023-02-08
2021-03-31$2.20M
10-Q · filed 2022-05-05
$2.80M
derived: sum of 2 quarters · filed 2023-02-08
$3.30M
derived: sum of 3 quarters · filed 2023-02-08
$5.38M
derived: sum of 4 quarters · filed 2023-02-08
2020-12-31$601.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08
$1.10M
derived: sum of 2 quarters · filed 2023-02-08
$3.18M
derived: sum of 3 quarters · filed 2023-02-08
$4.51M
10-K · filed 2023-02-08
2020-09-30$503.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$2.58M
derived: sum of 2 quarters · filed 2021-11-04
$3.91M
10-Q · filed 2021-11-04
$6.62M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$2.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$3.41M
10-Q · filed 2021-08-09
$6.12M
derived: sum of 3 quarters · filed 2022-02-28
$7.61M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$1.33M
10-Q · filed 2021-05-04
$4.04M
derived: sum of 2 quarters · filed 2022-02-28
$5.53M
derived: sum of 3 quarters · filed 2022-02-28
$6.27M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$2.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$4.20M
derived: sum of 2 quarters · filed 2022-02-28
$4.94M
derived: sum of 3 quarters · filed 2022-02-28
$5.73M
10-K · filed 2022-02-28
2019-09-30$1.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$2.23M
derived: sum of 2 quarters · filed 2020-11-09
$3.02M
10-Q · filed 2020-11-09
$7.19M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$738.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$1.53M
10-Q · filed 2020-08-05
$5.70M
derived: sum of 3 quarters · filed 2021-03-01
$10.20M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$796.00K
10-Q · filed 2020-05-06
$4.96M
derived: sum of 2 quarters · filed 2021-03-01
$9.46M
derived: sum of 3 quarters · filed 2021-03-01
$16.91M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$4.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$8.67M
derived: sum of 2 quarters · filed 2021-03-01
$16.12M
derived: sum of 3 quarters · filed 2021-03-01
$35.92M
10-K · filed 2021-03-01
2018-09-30$4.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$11.95M
derived: sum of 2 quarters · filed 2019-11-07
$31.76M
10-Q · filed 2019-11-07
$41.45M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$7.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$27.26M
10-Q · filed 2019-08-08
$36.95M
derived: sum of 3 quarters · filed 2020-02-27
$43.15M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$19.81M
10-Q · filed 2019-05-09
$29.50M
derived: sum of 2 quarters · filed 2020-02-27
$35.70M
derived: sum of 3 quarters · filed 2020-02-27
$38.83M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$9.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$15.89M
derived: sum of 2 quarters · filed 2020-02-27
$19.03M
derived: sum of 3 quarters · filed 2020-02-27
$20.23M
10-K · filed 2020-02-27
2017-09-30$6.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$9.33M
derived: sum of 2 quarters · filed 2018-11-06
$10.54M
10-Q · filed 2018-11-06
$11.53M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$3.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$4.34M
10-Q · filed 2018-08-01
$5.34M
derived: sum of 3 quarters · filed 2019-02-26
$5.72M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$1.21M
10-Q · filed 2018-05-08
$2.20M
derived: sum of 2 quarters · filed 2019-02-26
$2.59M
derived: sum of 3 quarters · filed 2019-02-26
$3.33M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$995.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$1.38M
derived: sum of 2 quarters · filed 2019-02-26
$2.13M
derived: sum of 3 quarters · filed 2019-02-26
$3.02M
10-K · filed 2019-02-26
2016-09-30$386.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$1.13M
derived: sum of 2 quarters · filed 2017-11-09
$2.02M
10-Q · filed 2017-11-09
$2.30M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$748.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
$1.64M
10-Q · filed 2017-08-07
$1.91M
derived: sum of 3 quarters · filed 2018-02-27
$1.92M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$891.00K
10-Q · filed 2017-05-04
$1.16M
derived: sum of 2 quarters · filed 2018-02-27
$1.18M
derived: sum of 3 quarters · filed 2018-02-27
$1.18M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$271.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$285.00K
derived: sum of 2 quarters · filed 2018-02-27
$285.00K
derived: sum of 3 quarters · filed 2018-02-27
$290.00K
10-K · filed 2018-02-27
2015-09-30$14.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$14.00K
derived: sum of 2 quarters · filed 2016-11-04
$19.00K
10-Q · filed 2016-11-04
$55.00K
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$5.00K
10-Q · filed 2016-08-08
$41.00K
derived: sum of 3 quarters · filed 2017-03-09
$46.00K
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31$5.00K
10-Q · filed 2016-05-06
$41.00K
derived: sum of 2 quarters · filed 2017-03-09
$46.00K
derived: sum of 3 quarters · filed 2017-03-09
$50.00K
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31$36.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$41.00K
derived: sum of 2 quarters · filed 2017-03-09
$45.00K
derived: sum of 3 quarters · filed 2017-03-09
$46.00K
10-K · filed 2017-03-09
2014-09-30$5.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$9.00K
derived: sum of 2 quarters · filed 2015-11-06
$10.00K
10-Q · filed 2015-11-06
$10.00K
derived: sum of 4 quarters · filed 2016-03-04
2014-06-30$4.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
$5.00K
10-Q · filed 2015-08-07
$5.00K
derived: sum of 3 quarters · filed 2016-03-04
2014-03-31$1.00K
10-Q · filed 2015-05-11
$1.00K
derived: sum of 2 quarters · filed 2016-03-04
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04
$3.00K
10-K · filed 2016-03-04
2013-09-30$3.00K
10-Q · filed 2014-11-12
2012-12-31$9.00K
10-K · filed 2015-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Vaxart, Inc. (VXRT)United States$0.080B3.84
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37